Skip to main content
January 20, 2021
Psychedelic medicine biotech firm MindMed has announced the launch of a clinical trial that will evaluate the use of MDMA and LSD in combination. The trial will look to determine whether MDMA can increase positive subject drug effects and reduce negative emotions and anxiety that are sometimes…
January 18, 2021
Awakn Life Sciences has announced plans to conduct a Phase IIb trial to study MDMA-assisted psychotherapy as a treatment for patients with alcohol use disorder, with PRA Health Sciences as the contract research organization for the project.
January 18, 2021
UFC, the top mixed martial arts promotion in the United States, has approached researchers at Johns Hopkins University to explore the potential use of psychedelics in treatment for its fighters, according to a report published by Yahoo.
January 13, 2021
Mind Cure Health, a Vancouver, British Columbia-based mental health firm, announced this week that it has signed a letter of intent to acquire an ownership interest in ATMA Journey Centers, a Calgary, Alberta-based treatment center that provides psychedelic-assisted therapy for patients who qualify…
January 12, 2021
Repeated intravenous (IV) ketamine infusions may significantly reduce the severity of symptoms in individuals with chronic post-traumatic stress disorder (PTSD).
January 08, 2021
Western classical music, largely viewed as the best music to accompany psychedelic therapy sessions, might not actually offer unique benefits in comparison to other genres, per the findings of a study conducted by researchers at the Johns Hopkins University School of Medicine. The study was…
December 17, 2020
Psychedelic biotech firm MindMed announced the successful completion of a pre-investigational new drug (IND) meeting with the FDA on its development of LSD-assisted therapy for the treatment of an anxiety disorder. MindMed said it plans to open the IND with the FDA in August, with a Phase 2b…
December 15, 2020
Numinus Wellness, the Vancouver-based mental health and wellness company, announced on Tuesday that it has acquired Montreal-based Mindspace Psychology Services in a deal aimed at expanding its psychedelic-assisted psychotherapy offerings. Mindspace generated $1.7 million in revenue over the past…
December 10, 2020
Cybin, a Canadian psychedelic life services company, announced this week that it has acquired Adelia Therapeutics, a global pharmaceutical firm whose founders previously partnered with Johnson & Johnson to develop the ketamine-based drug Spravato. Cybin acquired 100% of Adelia shares for $15.…
December 03, 2020
Numinus Wellness and the Multidisciplinary Association for Psychedelic Studies Public Benefit Corp. (MAPS PBC), a MAPS subsidiary, have announced they are seeking approval for the use of MDMA-assisted psychotherapy for post-traumatic stress disorder through a compassionate access trial in Canada.
Back to Top